Please login to the form below

Not currently logged in
Email:
Password:

felodipine

This page shows the latest felodipine news and features for those working in and with pharma, biotech and healthcare.

Recordati acquires AstraZeneca blood pressure brands

Recordati acquires AstraZeneca blood pressure brands

The agreement sees the Milan-based pharmaceutical group acquire rights to AZ’s Seloken ZOK (metoprolol succinate) and Logimax fixed dose combination (metoprolol succinate and felodipine) treatments in Europe.

Latest news

  • AZ adds gout drug Zurampic to asset sale AZ adds gout drug Zurampic to asset sale

    Last month, AZ sold European rights to its opioid-induced constipation treatment Moventig (naloxegol) to ProStrakan and transferred Chinese rights to two elderly cardiovascular drugs - Plendil (felodipine) and Imdur (isosorbide mononitrate) -

  • AZ offloads more products in slimming drive AZ offloads more products in slimming drive

    Meanwhile, earlier this week AZ also transferred Chinese rights to two elderly cardiovascular drugs - Plendil (felodipine) and Imdur (isosorbide mononitrate) - to China Medical System Holdings in a $500m deal.

  • Lifting the fog

    Oleptro (Angelini Labopharm). Major depressive disorder. US. Felodipine sustained-release. (Jiangbo Pharmaceuticals).

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    Being particularly active in out-licensing, AstraZeneca has granted a licence to China Medical System (CMS) in return for $310m to sell Plendil (felodipine), a calcium antagonist for hypertension in China. ... collaboration expanded. 500. AstraZeneca/

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics